02021Medical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description><span class="ui-provider gf b c d e f g h i j k l m n o p q r s t u v w x y z ab ac ae af ag ah ai aj ak" dir="ltr" xmlns="http://www.w3.org/1999/xhtml">July 1, 2022 – June 30, 2024</span></Description><Category><Description/><Title>Biennial Report3887660Minnesota Board of Medical Practice Affirmative Action PlanMinnesota Board of Medical Practice Affirmative Action Plan for July 1, 2022 – June 30, 2024<custom:Link urlOnly="true" type="Component" destination="tcm:21-388775" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2023-09-07T20:25:52Z21388775/boards/assets/2022-2024%20AAP%20Minnesota%20Board%20of%20Medical%20Practice.%20signed_tcm21-36559.pdf2023-09-07T17:21:27ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>July 1, 2018 - June 30, 2020</Description><Category><Description/><Title>Biennial Report3887660Biennial Report 2020Biennial Report 2020<custom:Link urlOnly="true" type="Component" destination="tcm:21-463760" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2020-07-01T20:14:35Z21463760/boards/assets/2020%20Biennial%20Report_tcm21-463762.pdf2021-01-20T21:11:57ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description><p xmlns="http://www.w3.org/1999/xhtml">The Boards of Medical Practice, Nursing and Pharmacy have collaboratively developed and adopted a Joint Statement on the Prescribing of Opioid Antagonists in response to the increasing use, misuse and overdose deaths related to opioids.</p> <p xmlns="http://www.w3.org/1999/xhtml"><a href="/boards/assets/Joint%20Statement%20on%20the%20Prescribing%20of%20Opioid%20Antagonists%2C%20July%2014%2C%202018_tcm21-346485.pdf" title="July 14, 2018, Joint Statement on the Prescribing of Opioid Antagonists" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="July 14, 2018, Joint Statement on the Prescribing of Opioid Antagonists">Joint Statement on the Prescribing of Opioid Antagonists</a></p></Description><Category><Description/><Title>Joint Statements3889810Prescribing of Opioid AntagonistsPrescribing of Opioid Antagonists<custom:Link urlOnly="true" type="Component" destination="tcm:21-388982" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2018-07-14T13:32:22Z21388982/boards/assets/Joint%20Statement%2C%20Prescribing%20of%20Opioid%20Antagonists_tcm21-346484.pdf2021-01-11T15:57:16ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>July 1, 2017 - June 30, 2018</Description><Category><Description/><Title>Biennial Report3887660Biennial Report 2018Biennial Report 2018<custom:Link urlOnly="true" type="Component" destination="tcm:21-388767" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2018-07-01T20:14:35Z21388767/boards/assets/2018%20HLB%20Biennial%20Report%20Final_tcm21-362008.pdf2019-06-14T20:27:37ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>According to a new American Medical Association Report, the number of opioid prescriptions issued nationwide dropped by 22 percent between 2014 and 2017.  The report found that over that time period, the number of opioid prescriptions decreased by more than 55 million, decreases occurred in every state and the number of opioid prescriptions has decreased for the past five consecutive years.</Description><Category><Description/><Title>Press Release3889850Press Release- American Medical AssociationPress Release- American Medical Association<custom:Link urlOnly="true" type="Component" destination="tcm:21-388986" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2018-05-31T13:34:45Z21388986http://www.ama-assn.org/ama-report-shows-national-progress-toward-reversing-opioid-epidemic2019-06-18T14:11:46ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>The guidelines provide a framework for the appropriate use of opioid analgesia within the larger context of pain management.</Description><Category><Description/><Title>Guidelines3889870Opioid Prescribing GuidelinesOpioid Prescribing Guidelines<custom:Link urlOnly="true" type="Component" destination="tcm:21-388988" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2018-03-18T13:36:41Z21388988https://mn.gov/dhs/assets/mn-opioid-prescribing-guidelines_tcm1053-337012.pdf2019-06-18T14:12:02ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>The report includes national data on physician licensure and discipline, demographic trends and information about licensed physicians, and details about the structure and operations of each of the nation’s 70 state and territorial medical boards.</Description><Category><Description/><Title>Federal Reports3889890U.S. Medical Regulatory Trends and ActionsU.S. Medical Regulatory Trends and Actions<custom:Link urlOnly="true" type="Component" destination="tcm:21-388990" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2018-01-01T14:43:03Z21388990https://www.fsmb.org/siteassets/advocacy/publications/us-medical-regulatory-trends-actions.pdf2019-06-18T14:12:04ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description><p xmlns="http://www.w3.org/1999/xhtml"><strong>Department of Defense/Veterans Affairs</strong></p> <p xmlns="http://www.w3.org/1999/xhtml"> Developed by a panel of multidisciplinary experts, it provides a clear explanation of the logical relationships between various care options and health outcomes while rating both the quality of the evidence and the strength of the recommendation. </p></Description><Category><Description/><Title>Federal Reports388989Joint Statements3889810Opioid Therapy for Chronic Pain GuidelinesOpioid Therapy for Chronic Pain Guidelines<custom:Link urlOnly="true" type="Component" destination="tcm:21-388992" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2017-02-18T14:46:46Z21388992https://www.healthquality.va.gov/guidelines/Pain/cot/VADoDOTCPGProviderSummary022817.pdf2019-06-18T14:12:02ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>The Minnesota Board of Medical Practice reaffirmed its adoption of the Statement of Support for a Statewide Culture of Learning, Justice, and Accountability at its January 14, 2017, Board Meeting.</Description><Category><Description/><Title>Reports117520Statement of Support for a Statewide Culture of Learning, Justice, and AccountabilityStatement of Support for a Statewide Culture of Learning, Justice, and Accountability<custom:Link urlOnly="true" type="Component" destination="tcm:21-388998" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2017-01-14T15:05:32Z21388998/boards/assets/MAPS%20Statement%202-22-06%20Reaffirmed%20January%2014%2C%202017_tcm21-274057.pdf2019-06-18T14:11:52ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>July 1, 2014 - June 30, 2016</Description><Category><Description/><Title>Biennial Report3887660Biennial Report 2016Biennial Report 2016<custom:Link urlOnly="true" type="Component" destination="tcm:21-388769" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2016-07-01T20:19:44Z21388769/boards/assets/Biennial%20Report%2C%207-1-2014%20to%206-30-2016%2C%20MN%20Health-Related%20Licensing%20Boards_tcm21-277099.pdf2019-06-14T20:27:34ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description><p xmlns="http://www.w3.org/1999/xhtml"><strong>Minnesota Boards of Medical Practice, Nursing, and Pharmacy</strong></p> <p xmlns="http://www.w3.org/1999/xhtml">The Boards of Medical Practice, Nursing and Pharmacy collaboratively developed and adopted a Joint Statement on the Impact of Health Conditions and Medication Use on the Operation of Vehicles.  The Joint Statement is meant to offer guidance to pharmacists and licensed healthcare providers who are authorized to prescribe medications. </p></Description><Category><Description/><Title>Joint Statements3889810Impact of Health Conditions and Medication Use on the Operation of VehiclesImpact of Health Conditions and Medication Use on the Operation of Vehicles<custom:Link urlOnly="true" type="Component" destination="tcm:21-388995" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2016-06-01T13:59:07Z21388995null/boards/assets/Joint%20Statement%20NTSB%20with%20APA_tcm21-116260.pdf2019-06-18T14:11:57ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description><p xmlns="http://www.w3.org/1999/xhtml"><strong>Institute for Clinical Systems Improvement</strong></p> <p xmlns="http://www.w3.org/1999/xhtml">Pain Assessment, Non-Opioid Treatment Approaches and Opioid Management</p></Description><Category><Description/><Title>Guidelines388987Federal Reports3889890ICSI Pain GuidelinesICSI Pain Guidelines<custom:Link urlOnly="true" type="Component" destination="tcm:21-388993" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2016-06-01T13:50:47Z21388993https://www.icsi.org/guideline/pain/2019-06-18T14:12:02ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care.</Description><Category><Description/><Title>Guidelines388987Federal Reports388989Controlled Substances3890670CDC Guideline for Prescribing Opioids for Chronic PainCDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016<custom:Link urlOnly="true" type="Component" destination="tcm:21-388994" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2016-03-18T13:54:18Z21388994https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fvolumes%2F65%2Frr%2Frr6501e1er.htm2019-06-18T16:34:48ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description><p xmlns="http://www.w3.org/1999/xhtml"><strong>Boards of Medical Practice, Nursing, and Pharmacy</strong></p> <p xmlns="http://www.w3.org/1999/xhtml">Pain management and opioid prescription drug abuse are significant issues in healthcare today. There is a critical balance between preventing opioid misuse and managing pain. In the United States, 46 people die from a prescription opioid overdose each day. In 2007, the cost of prescription opioid abuse was estimated at $55.7 billion. In 2013, the leading cause of death due to injury was drug overdose with 51.8% being related to prescription drugs.  Click the above link to read the full statement.</p></Description><Category><Description/><Title>Joint Statements388981Controlled Substances3890670Pain Management - Joint Statement 2015Pain Management<custom:Link urlOnly="true" type="Component" destination="tcm:21-388996" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2015-12-30T15:01:05Z21388996null/boards/assets/Joint_Statement_on_Pain_Management.pdf_tcm21-36518.pdf2019-06-18T16:35:00ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>July 1, 2012 - June 30, 2014</Description><Category><Description/><Title>Biennial Report3887660Biennial Report 2014Biennial Report 2014<custom:Link urlOnly="true" type="Component" destination="tcm:21-388770" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2015-07-01T20:21:19Z21388770null/boards/assets/2014%20Biennial%20Report_tcm21-36556.pdf2019-06-14T20:27:34ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description/><Category><Description/><Title>Guidelines3889870Lymes Disease Resolution 2014Lymes Disease Resolution 2014<custom:Link urlOnly="true" type="Component" destination="tcm:21-388999" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2014-11-08T15:10:21Z21388999null/boards/assets/2014%20Board%20Resolution%20Relating%20to%20Lyme%20Disease_tcm21-36641.pdf2019-06-18T14:11:52ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description><p xmlns="http://www.w3.org/1999/xhtml">In 1997, the FSMB undertook an initiative to develop model guidelines and to encourage state medical boards and other health care regulatory agencies to adopt policies encouraging safe and effective treatment of patients with pain</p></Description><Category><Description/><Title>Controlled Substances389067Federal Reports388989Guidelines3889870Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain<custom:Link urlOnly="true" type="Component" destination="tcm:21-389068" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2013-07-01T16:35:49Z21389068/boards/assets/FSMB%20Model%20Policy_tcm21-255733.pdf2019-06-18T16:36:10ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>July 1, 2010 - June 30, 2012</Description><Category><Description/><Title>Biennial Report3887660Biennial Report 2012Biennial Report 2012<custom:Link urlOnly="true" type="Component" destination="tcm:21-388771" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2012-07-01T20:23:06Z21388771null/boards/assets/Biennial%20Report%202012_tcm21-36557.pdf2019-06-14T20:27:34ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>Report to the Legislature in Compliance with Minnesota Statutes Section 3D.06</Description><Category><Description/><Title>Legislative Reports3887760Sunset Review Report 2012Sunset Review Report 2012<custom:Link urlOnly="true" type="Component" destination="tcm:21-388676" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2012-01-01T16:36:53Z21388676null/boards/assets/BMP%20Sunset%20Review%20Report%202012_tcm21-36479.pdf2019-06-18T14:11:52ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description>July 1, 2008 - June 30, 2010</Description><Category><Description/><Title>Biennial Report3887660Biennial Report 2010Biennial Report 2010<custom:Link urlOnly="true" type="Component" destination="tcm:21-388772" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2010-07-01T20:24:41Z21388772null/boards/assets/BMP-Biennial-Report-2010.pdf_tcm21-36558.pdf2019-06-14T20:27:32ZMedical Practices Board Documents388665<Publisher/><Source/><Rights/><Identifier/><Format/><Language>eng</Language><SubjectControlled/></DublinCore></metadata><Description/><Category><Description/><Title>Guidelines3889870Lymes Disease Resolution 2010Lymes Disease Resolution 2010<custom:Link urlOnly="true" type="Component" destination="tcm:21-389000" templateURI="tcm:0-0-0" origin="tcm:0-0-0" />2010-03-13T15:09:34Z21389000null/boards/assets/2010%20Lyme%20Disease%20Resolution.pdf_tcm21-36642.pdf2019-06-18T14:11:52Z